Ethics of Gene Editing
By Betty Rollin,
KQED Religion & Ethics Newsweekly
| 07. 02. 2015
[with CGS's Marcy Darnovsky]
<span id="XinhaEditingPostion"></span>
A promising new medical technology has the potential to cure many genetic diseases by deleting or replacing defective genes. But ethicist Marcy Darnovsky of the Center for Genetics and Society is concerned about the safety of the technology, the unintended consequences of gene alteration for future generations, and the possibility of wealthy parents using the technology to “enhance” their children, regardless of medical necessity.
Image via WikiMedia Commons.
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...